Drug price controls aren’t the prescription Kansas needs

KANSAS CITY STAR

When President Donald Trump took office, he did so with a clear mandate: do what must be done to make America great. He immediately got to work securing our borders, creating jobs and bringing down everyday costs for working families. But of all the rising expenses Americans face, none has been harder to control than prescription drug prices. Many ideas have been tried with mixed results, and while we’ve yet to find the perfect fix, we know which policies fail.

Congress is now considering the MFN or Most Favored Nation model, which would tie U.S. drug prices to those paid overseas. While well-intentioned, MFN relies on foreign price controls and risks, limiting innovation and access to lifesaving therapies. As a child of immigrants who grew up under socialized health care, I know the risk is not worth the reward — especially when there are alternative approaches that would yield better outcomes with a free market approach.

Read more here.